Pacific Biosciences of California, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2025
Total Assets: $784.1M
Liabilities Breakdown FY2025
Total Liabilities: $778.7M
Asset Breakdown
Total Assets: $784.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $63.7M | 8.1% |
| Accounts Receivable | $35.4M | 4.5% |
| Inventory | $49.3M | 6.3% |
| Property, Plant & Equipment | $24.1M | 3.1% |
| Goodwill | $317.8M | 40.5% |
| Intangible Assets | $15.1M | 1.9% |
| Other Assets | $278.6M | 35.5% |
Liabilities Breakdown
Total Liabilities: $778.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $20.8M | 2.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $758.0M | 97.3% |